Patient referral for elective coronary angiography: challenging the current strategy

Similar documents
Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

New Stable Chest Pain Guidance in the UK NICE to have, difficult to implement

Current and Future Imaging Trends in Risk Stratification for CAD

CASE from South Korea

The 2016 NASCI Keynote: Trends in Utilization of Cardiac Imaging: The Coronary CTA Conundrum. David C. Levin, M.D.

Diagnostic Algorithms

Optimal testing for coronary artery disease in symptomatic and asymptomatic patients

Invited Experts' Case Presentation and 5-Slides Focus Review

Test in Subjects with Suspected CAD Anatomic Study is Better

ESC CONGRESS 2010 Stockholm, august 28 september 1, 2010

PERIOPERATIVE MYOCARDIAL INFARCTION THE ANAESTHESIOLOGIST'S VIEW

CT FFR: Are you ready to totally change the way you diagnose Coronary Artery Disease?

FFR in Multivessel Disease

The presenter does not have any potential conflicts of interest to disclose

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal

FFR-CT Not Ready for Primetime

Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome

Maria Angela S. Cruz-Anacleto, MD

Hybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future

SYNTAX III REVOLUTION Trial Press briefing conference. Prof. Patrick W. Serruys MD, PhD Principal Investigator Imperial College of London

Benefit of Performing PCI Based on FFR

New Insight about FFR and IVUS MLA

Stable Angina: Indication for revascularization and best medical therapy

Chest pain. One problem different approaches... Question 1 what is your choice? In-/Exclusion Criteria

How to investigate (Cardiac) Chest Pain

DECLARATION OF CONFLICT OF INTEREST

Patient characteristics Intervention Comparison Length of followup

Type of intervention Diagnosis. Economic study type Cost-effectiveness analysis.

High Value Evaluation of Chest Pain. Zoom Tips

Diabetes and Occult Coronary Artery Disease

Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology

MILITARY MEDICINE, Vol. 175, July MILITARY MEDICINE, 175, 7:529, 2010

Bayes Theorem and diagnostic tests with application to patients with suspected angina

PCIs on Intermediate Lesions NCDR Cath-PCI Registry

FFR? FFR-CT? Ischaemia testing?

PET myocard perfusion & viability Riemer Slart

Combining Coronary Artery Calcium Scanning with SPECT/PET Myocardial Perfusion Imaging

Pamela S. Douglas, Gianluca Pontone, Mark A. Hlatky, Manesh R. Patel, Campbell Rogers, Bernard De Bruyne. On behalf of the PLATFORM Investigators

Debate Should we use FFR? I will say NO.

What do the guidelines say?

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

FFR-Guided PCI. 4 th Imaging and Physiology Summit October 29 th, 2010 Seoul, Korea. Stanford

Intervention: How and to which extent is technology helping us?

Stress ECG is still Viable in Suleiman M Kharabsheh, MD, FACC Consultant Invasive Cardiologist KFHI KFSHRC-Riyadh

Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines

The Role of Computed Tomography in the Diagnosis of Coronary Atherosclerosis

Management of stable CAD FFR guided therapy: the new gold standard

What the Cardiologist needs to know from Medical Images

Screening for Asymptomatic Coronary Artery Disease: When, How, and Why?

PERIOPERATIVE EVALUATION AND ANESTHETIC MANAGEMENT OF PATIENTS WITH CARDIAC DISEASE FOR NON CARDIAC SURGERY

Quality Payment Program: Cardiology Specialty Measure Set

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Efficiency

Rational use of imaging for viability evaluation

Diagnosis of CAD S Richard Underwood

Is computed tomography angiography really useful in. of coronary artery disease?

Effect of intravenous atropine on treadmill stress test results in patients with poor exercise capacity or chronotropic incompetence ABSTRACT

Εξελίξεις και νέες προοπτικές στην καρδιαγγειακή απεικόνιση CT. Σταμάτης Κυρζόπουλος Ωνάσειο Καρδιοχειρουργικό Κέντρο

Stress Testing:Which Study is Indicated for My Patient?

Cardiovascular Imaging Stress Echo

Long-term outcome after normal myocardial perfusion imaging in suspected ischaemic heart disease

Epicardial fat volume as a predictor of coronary vulnerable plaques using cardiac computed tomography in the patients with zero calcium score

The NICE chest pain guideline 1 year on. Jane S Skinner Consultant Community Cardiologist The Newcastle upon Tyne Hospitals NHS Foundation Trust

The role of Magnetic Resonance Imaging in the diagnosis of viability & Coronary Artery Disease

Use of Nuclear Cardiology in Myocardial Viability Assessment and Introduction to PET and PET/CT for Advanced Users

Detailed Order Request Checklists for Cardiology

Clinical case in perspective. Cases from Poland

Welcome! To submit questions during the presentation: or Text:

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice

Impact of Body Mass Index and Metabolic Syndrome on the Characteristics of Coronary Plaques Using Computed Tomography Angiography

Reducing the Population Health Burden of Cardiovascular Disease

Ticagrelor compared with clopidogrel in patients with acute coronary syndromes the PLATO trial

Gene Expression Testing to Predict Coronary Artery Disease

Technical Meeting on: Current Role of Nuclear Cardiology in the Management of Cardiac Diseases Vienna, May 2008 Vienna International Centre

Calcium scoring Clinical and prognostic value

Abstract Background: Methods: Results: Conclusions:

Low fractional diastolic pressure in the ascending aorta increased the risk of coronary heart disease

Coronary microvascular dysfunction after elective percutaneous coronary intervention: correlation with exercise stress test results

DIAGNOSTIC TESTING IN PATIENTS WITH STABLE CHEST PAIN

Sung A Chang Department of Internal Medicine, Division of Cardiology, Sungkyunkwan University School of Medicine, Samsung Medical Center

Exercise Test: Practice and Interpretation. Jidong Sung Division of Cardiology Samsung Medical Center Sungkyunkwan University School of Medicine

The Latest on CT Fractional Flow Reserve. Dimitris Mitsouras, Ph.D.

Declaration of conflict of interest. Nothing to disclose

The Final 10-Year Follow-up Results from the Bari Randomized Trial J Am Coll Cardiol (2007) 49;1600-6

J. Schwitter, MD, FESC Section of Cardiology

Risk Stratification for CAD for the Primary Care Provider

CLINICAL CONSEQUENCES OF THE

Σεμινάριο Ομάδων Εργασίας Fractional Flow Reserve (FFR) Σε ποιούς ασθενείς; ΔΗΜΗΤΡΗΣ ΑΥΖΩΤΗΣ Επιστ. υπεύθυνος Αιμοδυναμικού Τμήματος, Βιοκλινική

CMR stress Perfusion: what's new?

MEDICAL POLICY. Proprietary Information of Excellus Health Plan, Inc. A nonprofit independent licensee of the BlueCross BlueShield Association

FFR Incorporating & Expanding it s use in Clinical Practice

Non-invasive diagnosis of coronary artery disease by exercise magnetocardiography

Coronary interventions

Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease

Microvascular Disease: How to Diagnose and What s its Treatment

Heart Failure and COPD: Common Partners, Common Problems. Nat Hawkins Liverpool Heart and Chest Hospital

Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association

Coronary Artery Disease - Reporting and Data System (CAD-RADS)

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium

FFR vs icecg in Coronary Bifurcations FIESTA ClinicalTrials.gov Identifier: NCT

Transcription:

Patient referral for elective coronary angiography: challenging the current strategy M. Santos, A. Ferreira, A. P. Sousa, J. Brito, R. Calé, L. Raposo, P. Gonçalves, R. Teles, M. Almeida, M. Mendes Cardiology Department Hospital Santa Cruz, Lisbon, Portugal European Society of Cardiology Congress 2011 Controversial issues in patients with stable ischaemic heart disease

CONFLICTS OF INTEREST

BACKGROUND - The evaluation of patients with suspected coronary artery disease (CAD) is based on clinical assessment, often supplemented by noninvasive tests. - Invasive coronary angiography (ICA) is the gold-standard for the diagnosis of CAD but has a relatively high cost, limited availability and a small but real risk of complications. - Despite the frequent use of noninvasive testing, a significant proportion of patients undergoing ICA do not have obstructive CAD.

PURPOSE - To assess the current patterns of noninvasive testing and appraise their diagnostic yield in symptomatic patients undergoing elective invasive coronary angiography for suspected CAD.

METHODS - Observational, cross sectional, prospective study performed at a single hospital centre serving an urban population of 402.000 inhabitants in Lisbon, Portugal. -Study population: the totality of patients referred for ICA evaluation of chest pain symptoms suspected of stable CAD between January 2006 and November 2010.

METHODS - Exclusion criteria: - acute coronary syndrome setting - previously known CAD (prior MI, PCI, CABG, or ICA stenosis >50%) - preoperative cardiac surgery evaluation or other motive - presenting symptom other than chest pain - negative result of noninvasive testing

METHODS - Obstructive CAD was defined as a 50% or more reduction in vessel diameter as compared to a nondiseased proximal segment. - Statistical analysis (SPSS Statistics v. 17.0): - Fisher s exact test (categorical data) - t-test (continuous data) - multivariate logistic regression - two-sided P-value less than 0.05 for significance

11523 coronary angiography procedures (2006-2010) 7479 procedures 5014 procedures 2852 procedures 1925 procedures RESULTS ACS setting, n=4044 prior CAD, n=2465 1892 procedures (2006-2010) preop evaluation or other, n=2162 presenting symptom other than chest pain, n=927 negative noninvasive test or incomplete information, n=33

RESULTS Population characteristics n= 1892 Age, years 64 ± 11 Male sex, n (%) 1141 (60.3) Body Mass Index, Kg/m2 28 ± 4 Cardiovascular risk factors, n (%) Hypertension Diabetes Active smoking Hypercholesterolemia 1484 (78.4) 521 (27.5) 215 (11.4) 1310 (69.2)

RESULTS - The overall prevalence of obstructive CAD in coronary angiography was 56.7%.

Patients, n RESULTS - The overall prevalence of obstructive CAD in coronary angiography was 56.7%. 900 600 300 0 351 (18.6%) 323 (17.1%) 351 (21.1%) 820 (43.3%) 3-vessel 2-vessel 1-vessel W/o obstructive CAD

RESULTS - Patients were referred for coronary angiography after previous positive noninvasive testing in 81.8% of cases.

RESULTS - Patients were referred for coronary angiography after previous positive noninvasive testing in 81.8% of cases. Positive noninvasive testing 1548 (81.8%) Treadmill exercise testing 40.6% Stress myocardial SPECT 35.8% Stress echocardiogram 2.9% Coronary CT angiography 2.5% Without previous testing 344 (18.2%)

RESULTS Obstructive CAD (n=1072) Absent obstrutive CAD (n=820) P value Age, years 65.7 ± 10.4 61.7± 11.0 <0.0001 Male sex, n (%) 71.7% 45.4% <0.0001 Body Mass Index, Kg/m2 27.6 ± 3.9 28.0 ± 4.5 0.03 Cardiovascular risk factors, % Hypertension 81.3% 74.6% <0.0001 Diabetes 32.5% 21.1% <0.0001 Active smoking 13.2% 8.9% 0.003 Hypercholesterolemia 71.9% 65.7% 0.004 Previous positive noninvasive testing 83.6% 79.5% 0.026

RESULTS Adjusted odds ratio 95% CI P value Age 1.05 1.04-1.06 <0.001 Male sex 3.45 2.80-4.24 <0.001 Hypertension 1.35 1.05-1.73 0.019 Diabetes 1.66 1.32-2.08 <0.001 Active smoking 1.91 1.36-2.69 <0.001 Hypercholesterolemia 1.30 1.05-1.61 0.017 Positive noninvasive testing 1.40 1.09-1.81 0.010

RESULTS - The proportion of patients with obstructive CAD remained unchanged during the study period, despite an increase in noninvasive testing. 2006 (n=442) 2007 (n=436) 2008 (n=329) 2009 (n=368) 2010 (n=317) P value Obstructive CAD 57.7% 59.6% 53.8% 55.7% 55.2% ns

RESULTS - The proportion of patients with obstructive CAD remained unchanged during the study period, despite an increase in noninvasive testing. 2006 (n=442) 2007 (n=436) 2008 (n=329) 2009 (n=368) 2010 (n=317) P value Obstructive CAD 57.7% 59.6% 53.8% 55.7% 55.2% ns Noninvasive testing 79.0% 79.1% 82.4% 82.3% 88.3% 0.008 Treadmill ECG 38.5% 42.4% 41.6% 38.9% 42.0% Stress SPECT 36.9% 32.1% 35.9% 36.7% 38.5% Stress echo 3.4% 3.4% 3.3% 2.7% 0.9% Coronary CTA 0.2% 1.1% 1.5% 4.1% 6.9%

DISCUSSION - Slightly more than half (58%) the patients undergoing elective coronary angiography for suspected CAD in our population did have obstructive lesions, despite that 4 out of 5 had a positive noninvasive test. - Patel et al reported an overall rate of 41% of patients with obstructive CAD, that varied significantly among different centres (from 23 to 100%). N Engl J Med 2010;362:886-95 J Am Coll Cardiol 2011;58:801 9

DISCUSSION - Positive noninvasive testing was only a mild independent predictor of obstructive CAD in our population (OR 1.40, p=0.01). - Study limitations: - pretest probability of CAD not available; - dichotomized classification of noninvasive tests as positive or negative for obstructive CAD; - the decision to perform non-invasive testing and the type of the test itself were decided by the attending physician s (not randomized).

CONCLUSION These results suggest that the current referral strategy for coronary angiography can be further improved.

c.miguel.santos@gmail.com

BACKUP SLIDE

RESULTS - Noninvasive tests positive predictive value (PPV): n PPV Treadmill exercise testing 768 60.7% Stress myocardial SPECT 678 53.0% Stress echocardiogram 54 59.3% Coronary CT angiography 48 81.3%

RESULTS - Noninvasive tests positive predictive value and adjusted odds ratio: n PPV Odds ratio 95% CI P Treadmill testing 768 60.7% 1.55 1.17-2.06 0.002 Stress SPECT 678 53.0% - - ns Stress echocardiogram 54 59.3% - - ns Coronary CT angio 48 81.3% 4.82 2.19-10.64 <0.001

RESULTS - Multivariable regression for myocardial revascularization (PCI or CABG), which was performed in 46.7% of patients: Adjusted odds ratio 95% CI P value Age 1.03 1.02-1.04 <0.001 Male sex 2.68 2.19-3.27 <0.001 Diabetes 1.59 1.28-1.96 <0.001 Active smoking 1.54 1.12-2.10 0.007 Positive noninvasive testing 1.59 1.24-2.04 <0.001

Guidelines on the management of stable angina pectoris European Society Cardiology 2006 CCTA 98 87 C-MRI 84-89 84 Eur Heart J 2008;29:531-56 Heart 2005;91:1110-17

RESULTS Obstructive CAD (n=1072) Absent obstrutive CAD (n=820) P value Age, years 65.7 ± 10.4 61.7± 11.0 <0.0001 Male sex, n (%) 769 (71.7) 372 (45.4) <0.0001 Body Mass Index, Kg/m2 27.6 ± 3.9 28.0 ± 4.5 0.03 Cardiovascular risk factors, n (%) Hypertension 872 (81.3) 612 (74.6) <0.0001 Diabetes 348 (32.5) 173 (21.1) <0.0001 Active smoking 142 (13.2) 73 (8.9) 0.003 Hypercholesterolemia 771 (71.9) 539 (65.7) 0.004 Previous positive noninvasive testing 896 (83.6) 652 (79.5) 0.026

RESULTS - The proportion of patients with obstructive CAD remained unchanged during the study period, despite an increase in noninvasive testing. 2006 (n=442) 2007 (n=436) 2008 (n=329) 2009 (n=368) 2010 (n=317) P value Obstructive CAD 255 (57.7%) 260 (59.6%) 177 (53.8%) 205 (55.7%) 175 (55.2%) ns Noninvasive testing Treadmill ECG Stress SPECT Stress echo Coronary CTA 349 (79.0%) 38.5% 36.9% 3.4% 0.2% 345 (79.1%) 42.4% 32.1% 3.4% 1.1% 271 (82.4%) 41.6% 35.9% 3.3% 1.5% 303 (82.3%) 38.9% 36.7% 2.7% 4.1% 280 (88.3%) 42.0% 38.5% 0.9% 6.9% 0.008